Author
M. Esteller
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2018-2023 · peak 6/yrCo-Author Collaboration Network
10 top collaborators · 12 mutual co-author links9 papers
Recent·Most cited
- Cancer BiologybioRxiv
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms
A. J. Arribas, S. Napoli, L. Cascione…·F. Bertoni
This study identifies ERBB4-mediated signaling as a mechanism of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms and shows that targeting ERBB signaling can restore sensitivity.
DOI 10.1158/1535-7163.mct-23-0068 - ImmunologybioRxivPreprint
Macrophage and neutrophil heterogeneity at single-cell spatial resolution in inflammatory bowel disease
A. Garrido-Trigo, A. Corraliza, M. Veny…·A. Salas
The paper identifies macrophage and neutrophil heterogeneity in inflammatory bowel disease using single-cell and spatial transcriptomics, revealing distinct subtypes and their potential roles in disease.
- Cell BiologybioRxivPreprint
IκBα controls dormancy induction in Hematopoietic stem cell development via retinoic acid
R. Thambyrajah, Z. Fadlullah, M. Proffitt…·A. Bigas
This study shows that IκBα regulates hematopoietic stem cell (HSC) dormancy by controlling retinoic acid signaling during development.
DOI 10.1101/2022.11.17.516971 - Cancer BiologybioRxiv
The spatial landscape of Cancer Hallmarks reveals patterns of tumor ecology
M. Sibai, S. Cervilla, D. Grases…·E. Porta-Pardo
The paper uses spatial transcriptomics to analyze Cancer Hallmarks in 63 tumors, revealing spatial patterns of hallmark activity and interdependencies between cancer and tumor microenvironment.
DOI 10.1016/j.celrep.2024.115229 - Cancer BiologybioRxivPreprint
GPR183 mediates the capacity of the novel CD47-CD19 bispecific antibody TG-1801 to heighten ublituximab-umbralisib (U2) anti-lymphoma activity
M. Ribeiro, N. Profitos-Peleja, J. C. Santos…·G. Roue
This study shows that TG-1801 enhances ublituximab's anti-lymphoma activity through GPR183-mediated mechanisms in B-NHL models.
DOI 10.1101/2022.03.31.486558 - Cancer BiologybioRxivPreprint
Cellular and clinical impact of Protein Phosphatase Enzyme epigenetic silencing in multiple cancer tissues.
This study identifies epimutations in Protein Phosphatase Enzymes and their interacting proteins in cancer tissues, showing their impact on clinical outcomes and therapeutic response.
DOI 10.1101/2022.03.03.482850 - BiochemistrybioRxiv
MeCP2-E1 isoform is a dynamically expressed, weakly DNA-bound protein with different protein and DNA interactions compared to MeCP2-E2
A. Martinez de Paz, L. Khajavi, H. Martin…·J. Ausio
This study compares MeCP2-E1 and E2 isoforms, showing differences in DNA binding, protein interactions, and dynamic behavior, with implications for their functional roles in chromatin regulation.